We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Molecular Biomarkers Pave Way for New Tests to Diagnose and Predict Breast Cancer

By LabMedica International staff writers
Posted on 20 Jun 2025

Despite playing essential roles in tissue development and immune protection, the contribution of proteoglycans in cancer remains poorly understood. More...

Some proteoglycans appear to shield the body from cancer, while others can accelerate tumor growth. This lack of clarity presents a diagnostic and therapeutic challenge, particularly in breast cancer. Now, researchers have uncovered specific patterns of proteoglycan expression linked to breast cancer, offering a potential pathway to more accurate diagnostics and targeted treatments.

The research was conducted by scientists at Thomas Jefferson University (Philadelphia, PA, USA), who sought to explore the role of proteoglycans in breast cancer development and progression. By analyzing genetic data from over 1,000 tumor tissue samples, the team aimed to better understand how these large biomolecules behave in malignancies. Using a machine learning algorithm, the team identified two distinct proteoglycan expression profiles in tumor tissues. One group of proteoglycans was found at elevated levels in tumors, while the other was significantly reduced. Importantly, these patterns correlated with disease severity—proteoglycans that promote cell proliferation were linked to more aggressive tumors, whereas those that suppress cell growth were associated with less malignant tumors.

The findings, published in Proteoglycan Research, open the door to practical applications in both diagnostics and treatment. The researchers suggest that these proteoglycan patterns could be used to develop more precise diagnostic tests and prognostic tools, enabling physicians to tailor treatment strategies more effectively based on tumor aggressiveness. Looking ahead, the team plans to investigate whether these proteoglycan biomarkers are relevant in other cancers, such as those affecting the skin, pancreas, and colon. Additionally, early-stage efforts are underway to develop an injectable proteoglycan-based therapy designed to prevent cancer metastasis—potentially marking a major step forward in cancer care.

“It’s the first comprehensive study on proteoglycans in breast cancer,” said Thomas Jefferson University researcher Renato Iozzo, MD, who led the research. “It is absolutely fundamental to have better biomarkers for breast cancer. This is really the beginning.”

Related Links:
Thomas Jefferson University


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more

Pathology

view channel
Image: A tool uses artificial intelligence and high-resolution imaging to track senescent cells (Courtesy of Adobe Stock)

AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease

Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.